Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
A. Prasanth Saraswati(University of Siena), Giuseppe Campiani(University of Siena), Niamh McCabe(Queen's University Belfast), Daniela M. Zisterer(Trinity College Dublin), Alessandro Grillo(University of Siena), Nicola Relitti(University of Siena), Francesca Vanni(University of Siena), Stefania Butini(University of Siena), Magda Ghanim(Trinity College Dublin), David W. Christianson(California University of Pennsylvania), Manfred Jung(University of Freiburg), Cristina Ulivieri(University of Siena), Giovina Ruberti(National Research Council), Federica Sarno(University of Campania "Luigi Vanvitelli"), Richard Turkington(Queen's University Belfast), Vincent P. Kelly(Trinity College Dublin), Stefania Lamponi(University of Siena), Lucia Altucci(Biogem), Jeff O’Sullivan(Trinity College Dublin), Ola Ibrahim(Pakistan Institute of Nuclear Science and Technology), Giulia Chemi(University of Siena), Fulvio Saccoccia(National Research Council), Simone Brogi(University of Pisa), Stefano Federico(University of Siena), Patricia Hannon Barroeta(Trinity College Dublin), Daniel Herp(University of Freiburg), Margherita Brindisi(University of Naples Federico II), Rebecca Amet(Trinity College Dublin), Antonella Di Costanzo(University of Campania "Luigi Vanvitelli"), Sandra Gemma(University of Siena), J.D. Osko(University of Pennsylvania)
Cited by 44
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
|Nature Communications|2015|297